Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LIEBERMAN JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 215 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    2. Citrome, L; Volavka, J; Czobor, P; Sheitman, B; Lindenmayer, JP; McEvoy, J; Cooper, TB; Chakos, M; Lieberman, JA
      Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia

      PSYCHIATRIC SERVICES
    3. Schneider, LS; Tariot, PN; Lyketsos, CG; Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Small, GW; Lebowitz, B; Lieberman, JA
      National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    4. Lieberman, JA
      Starting a career in psychiatric research - The lessons of experience

      ACADEMIC PSYCHIATRY
    5. Urakubo, A; Jarskog, LF; Lieberman, JA; Gilmore, JH
      Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain

      SCHIZOPHRENIA RESEARCH
    6. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    7. Aghajanian, GK; Lieberman, JA
      Caveat emptor: Editors beware - Response

      NEUROPSYCHOPHARMACOLOGY
    8. Maynard, TM; Sikich, L; Lieberman, JA; LaMantia, AS
      Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia

      SCHIZOPHRENIA BULLETIN
    9. Lieberman, JA
      Hypothesis and hypothesis testing in the clinical trial

      JOURNAL OF CLINICAL PSYCHIATRY
    10. Basile, VS; Masellis, M; McIntyre, RS; Meltzer, HY; Lieberman, JA; Kennedy, JL
      Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle

      JOURNAL OF CLINICAL PSYCHIATRY
    11. Strous, RD; Pollack, S; Robinson, D; Sheitman, B; Lieberman, JA
      Seasonal admission patterns in first episode psychosis, chronic schizophrenia, and nonschizophrenic psychoses

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    12. Miyamoto, S; Mailman, RB; Lieberman, JA; Duncan, GE
      Blunted brain metabolic response to ketamine in mice lacking D-1A dopaminereceptors

      BRAIN RESEARCH
    13. Marx, CE; Jarskog, LF; Lauder, JM; Lieberman, JA; Gilmore, JH
      Cytokine effects on cortical neuron MAP-2 immunoreactivity: Implications for schizophrenia

      BIOLOGICAL PSYCHIATRY
    14. Basile, VS; Ozdemir, V; Masellis, M; Walker, ML; Heltzer, HY; Lieberman, JA; Potkin, SG; Alva, G; Kalow, W; Macciardi, FM; Kennedy, JL
      A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    15. Lieberman, JA; Golden, R; Stroup, S; McEvoy, J
      Drugs of the psychopharmacological revolution in clinical psychiatry

      PSYCHIATRIC SERVICES
    16. Sheitman, BB; Murray, MG; Snyder, JA; Silva, S; Goldman, R; Chakos, M; Volavka, J; Lieberman, JA
      IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness

      SCHIZOPHRENIA RESEARCH
    17. Perkins, DO; Leserman, J; Jarskog, LF; Graham, K; Kazmer, J; Lieberman, JA
      Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory

      SCHIZOPHRENIA RESEARCH
    18. Szeszko, PR; Bilder, RM; Lencz, T; Ashtari, M; Goldman, RS; Reiter, G; Wu, HW; Lieberman, JA
      Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia

      SCHIZOPHRENIA RESEARCH
    19. Levy, DL; Lajonchere, CM; Dorogusker, B; Min, D; Lee, S; Tartaglini, A; Lieberman, JA; Mendell, NR
      Quantitative characterization of eye tracking dysfunction in schizophrenia

      SCHIZOPHRENIA RESEARCH
    20. Lewis, DA; Lieberman, JA
      Catching up on schizophrenia: Natural history and neurobiology

      NEURON
    21. Miyamoto, S; Leipzig, JN; Lieberman, JA; Duncan, GE
      Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice

      NEUROPSYCHOPHARMACOLOGY
    22. Lieberman, JA
      Clinical research in the age of neuroscience

      NEUROPSYCHOPHARMACOLOGY
    23. Overstreet, DH; Moy, SS; Lubin, DA; Gause, LR; Lieberman, JA; Johns, JM
      Enduring effects of prenatal cocaine administration on emotional behavior in rats

      PHYSIOLOGY & BEHAVIOR
    24. Duncan, GE; Miyamoto, S; Leipzig, JN; Lieberman, JA
      Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    25. Marx, CE; Jarskog, LF; Lauder, JM; Gilmore, JH; Lieberman, JA; Morrow, AL
      Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia

      BRAIN RESEARCH
    26. Jarskog, LF; Gilmore, JH; Selinger, ES; Lieberman, JA
      Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia

      BIOLOGICAL PSYCHIATRY
    27. Marx, CE; Duncan, GE; Gilmore, JH; Lieberman, JA; Morrow, AL
      Olanzapine increases allopregnanolone in the rat cerebral cortex

      BIOLOGICAL PSYCHIATRY
    28. Javitt, DC; Shelley, AM; Silipo, G; Lieberman, JA
      Deficits in auditory and visual context-dependent processing in schizophrenia - Defining the pattern

      ARCHIVES OF GENERAL PSYCHIATRY
    29. Lieberman, JA; Weiskopf, RB; Kelley, SD; Feiner, J; Noorani, M; Leung, J; Toy, P; Viele, M
      Critical oxygen delivery in conscious humans is less than 7.3 ml O-2 center dot kg(-1) center dot min(-1)

      ANESTHESIOLOGY
    30. Jarskog, LF; Mattioli, MA; Perkins, DO; Lieberman, JA
      First-episode psychosis in a managed care setting: Clinical management andresearch

      AMERICAN JOURNAL OF PSYCHIATRY
    31. Bilder, RM; Goldman, RS; Robinson, D; Reiter, G; Bell, L; Bates, JA; Pappadopulos, E; Willson, DF; Alvir, JMJ; Woerner, MG; Geisler, S; Kane, JM; Lieberman, JA
      Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates

      AMERICAN JOURNAL OF PSYCHIATRY
    32. Lieberman, JA; Fenton, WS
      Delayed detection of psychosis: Causes, consequences, and effect on publichealth

      AMERICAN JOURNAL OF PSYCHIATRY
    33. Vincent, JB; Neves-Pereira, ML; Paterson, AD; Yamamoto, E; Parikh, SV; Macciardi, F; Gurling, HMD; Potkin, SG; Pato, CN; Macedo, A; Kovacs, M; Davies, M; Lieberman, JA; Meltzer, HY; Petronis, A; Kennedy, JL
      An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion lotus

      AMERICAN JOURNAL OF HUMAN GENETICS
    34. Yui, K; Goto, K; Ikemoto, S; Ishiguro, T; Angrist, B; Duncan, GE; Sheitman, BB; Lieberman, JA; Bracha, SH; Ali, SF
      Neurobiological basis of relapse prediction in stimulant-induced psychosisand schizophrenia: the role of sensitization

      MOLECULAR PSYCHIATRY
    35. Duncan, GE; Zorn, S; Lieberman, JA
      Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

      MOLECULAR PSYCHIATRY
    36. Szeszko, PR; Bilder, RM; Lencz, T; Pollack, S; Alvir, JMJ; Ashtari, M; Wu, HW; Lieberman, JA
      Investigation of frontal lobe subregions in first-episode schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    37. Gunduz, H; Woerner, MG; Alvir, JMJ; Degreef, G; Lieberman, JA
      Obstetric complications in schizophrenia, schizoaffective disorder and normal comparison subjects

      SCHIZOPHRENIA RESEARCH
    38. Breier, A; Lieberman, JA
      New antipsychotic drugs: Special issues and indications - Introduction

      SCHIZOPHRENIA RESEARCH
    39. Lieberman, JA; Aghajanian, GK
      Caveat emptor: Researcher beware

      NEUROPSYCHOPHARMACOLOGY
    40. Basile, VS; Masellis, M; Badri, F; Paterson, AD; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, F; Kennedy, JL
      Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    41. Keefe, RSE; Silva, SG; Perkins, DO; Lieberman, JA
      The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis

      SCHIZOPHRENIA BULLETIN
    42. Dawkins, K; Lieberman, JA; Lebowitz, BD; Hsiao, JK
      Antipsychotics: Past and future - National Institute of Mental Health Division of Services and Intervention Research Workshop, July 14, 1998

      SCHIZOPHRENIA BULLETIN
    43. Bilder, RM; Wu, HW; Bogerts, B; Ashtari, M; Robinson, D; Woerner, M; Lieberman, JA; Degreef, G
      Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study

      INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
    44. Duncan, GE; Sheitman, BB; Lieberman, JA
      An integrated view of pathophysiological models of schizophrenia

      BRAIN RESEARCH REVIEWS
    45. Lieberman, JA
      Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia

      JOURNAL OF CLINICAL PSYCHIATRY
    46. Stuart, MR; Lieberman, JA
      Clinics in office practice - Mental health - Preface

      PRIMARY CARE
    47. Lieberman, JA
      Medical education and patients' psychosocial needs

      JOURNAL OF FAMILY PRACTICE
    48. Bradford, DW; Chakos, MH; Sheitman, BB; Lieberman, JA
      Atypical antipsychotic drugs in treatment-refractory schizophrenia (vol 28, pg 620, 1998)

      PSYCHIATRIC ANNALS
    49. Alvir, JMJ; Woerner, MG; Gunduz, H; Degreef, G; Lieberman, JA
      Obstetric complications predict treatment response in first-episode schizophrenia

      PSYCHOLOGICAL MEDICINE
    50. Lee, H; Tarazi, FI; Chakos, M; Wu, HW; Redmond, M; Alvir, JM; Kinon, BJ; Bilder, R; Creese, I; Lieberman, JA
      Effects of chronic treatment with typical and atypical antipsychotic drugson the rat striatum

      LIFE SCIENCES
    51. Duncan, GE; Miyamoto, S; Leipzig, JN; Lieberman, JA
      Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine

      BRAIN RESEARCH
    52. Lieberman, JA
      Schizophrenia: Comments on genes, development, risk factors, phenotype, and course

      BIOLOGICAL PSYCHIATRY
    53. Lieberman, JA
      Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

      BIOLOGICAL PSYCHIATRY
    54. Tamminga, CA; Lieberman, JA
      Schizophrenia research series: From molecule to public policy

      BIOLOGICAL PSYCHIATRY
    55. Szeszko, PR; Bilder, RM; Dunlop, JA; Walder, DJ; Lieberman, JA
      Longitudinal assessment of methylphenidate effects on oral word productionand symptoms in first-episode schizophrenia at acute and stabilized phases

      BIOLOGICAL PSYCHIATRY
    56. Robinson, D; Woerner, MG; Alvir, JMJ; Bilder, R; Goldman, R; Geisler, S; Koreen, A; Sheitman, B; Chakos, M; Mayerhoff, D; Lieberman, JA
      Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

      ARCHIVES OF GENERAL PSYCHIATRY
    57. Lieberman, JA
      Searching for the neuropathology of schizophrenia: Neuroimaging strategiesand findings

      AMERICAN JOURNAL OF PSYCHIATRY
    58. Leadbetter, RA; Shutty, MS; Elkashef, AM; Kirch, DG; Spraggins, T; Cail, WS; Wu, HW; Bilder, RM; Lieberman, JA; Wyatt, RJ
      MRI changes during water loading in patients with polydipsia and intermittent hyponatremia

      AMERICAN JOURNAL OF PSYCHIATRY
    59. Robinson, DG; Woerner, MG; Alvir, JMJ; Geisler, S; Koreen, A; Sheitman, B; Chakos, M; Mayerhoff, D; Bilder, R; Goldman, R; Lieberman, JA
      Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    60. Sanger, TM; Lieberman, JA; Tohen, M; Grundy, S; Beasley, C; Tollefson, GD
      Olanzapine versus haloperidol treatment in first-episode psychosis

      AMERICAN JOURNAL OF PSYCHIATRY
    61. Hinrichsen, GA; Lieberman, JA
      Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia

      ACTA PSYCHIATRICA SCANDINAVICA
    62. SNYDER PJ; BOGERTS B; WU HW; BILDER RM; DEORAS KS; LIEBERMAN JA
      ABSENCE OF THE ADHESIO INTERTHALAMICA AS A MARKER OF EARLY DEVELOPMENTAL NEUROPATHOLOGY IN SCHIZOPHRENIA - AN MRI AND POSTMORTEM HISTOLOGIC-STUDY

      Journal of neuroimaging
    63. ALVIR JMJ; WOERNER MG; LIEBERMAN JA
      THE ASSOCIATION BETWEEN POSITIVE SYMPTOM RATINGS AND NEGATIVE SYMPTOMRATINGS DIFFERS ACCORDING TO CLINICAL STATE

      Schizophrenia research
    64. SANGER TM; LIEBERMAN JA; TOHEN M; TOLLEFSON GD
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF FIRST EPISODE PSYCHOSIS

      Schizophrenia research
    65. MASELLIS M; BASILE V; MELTZER HY; LIEBERMAN JA; SEVY S; MACCIARDI FM; COLA P; HOWARD A; BADRI F; NOTHEN MM; KALOW W; KENNEDY JL
      SEROTONIN SUBTYPE-2 RECEPTOR GENES AND CLINICAL-RESPONSE TO CLOZAPINEIN SCHIZOPHRENIA-PATIENTS

      Neuropsychopharmacology
    66. LIEBERMAN JA; SHEITMAN B; CHAKOS M; ROBINSON D; SCHOOLER N; KEITH S
      THE DEVELOPMENT OF TREATMENT RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA - A CLINICAL AND PATHOPHYSIOLOGIC PERSPECTIVE

      Journal of clinical psychopharmacology
    67. LINSZEN DH; LIEBERMAN JA; VERHOEFF J
      INTRODUCTION

      International clinical psychopharmacology
    68. LIEBERMAN JA
      PATHOPHYSIOLOGY IN THE CLINICAL COURSE OF SCHIZOPHRENIA

      International clinical psychopharmacology
    69. MARX CE; LIEBERMAN JA
      PSYCHONEUROENDOCRINOLOGY OF SCHIZOPHRENIA

      The Psychiatric clinics of North America
    70. MILLER CH; MOHR F; UMBRICHT D; WOERNER M; FLEISCHHACKER WW; LIEBERMAN JA
      THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE, AND CONVENTIONAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    71. LIEBERMAN JA
      MAXIMIZING CLOZAPINE THERAPY - MANAGING SIDE-EFFECTS

      The Journal of clinical psychiatry
    72. BRADFORD DW; CHAKOS MH; SHEITMAN BB; LIEBERMAN JA
      ATYPICAL ANTIPSYSHOTIC DRUGS IN TREATMENT-REFRACTORY SCHIZOPHRENIA

      Psychiatric annals
    73. SHEITMAN BB; LIEBERMAN JA
      THE NATURAL-HISTORY AND PATHOPHYSIOLOGY OF TREATMENT-RESISTANT SCHIZOPHRENIA

      Journal of Psychiatric Research
    74. DUNCAN GE; LEIPZIG JN; MAILMAN RB; LIEBERMAN JA
      DIFFERENTIAL-EFFECTS OF CLOZAPINE AND HALOPERIDOL ON KETAMINE-INDUCEDBRAIN METABOLIC-ACTIVATION

      Brain research
    75. LIEBERMAN JA; MAILMAN RB; DUNCAN G; SIKICH L; CHAKOS M; NICHOLS DE; KRAUS JE
      SEROTONERGIC BASIS OF ANTIPSYCHOTIC DRUG EFFECTS IN SCHIZOPHRENIA

      Biological psychiatry
    76. CRANDALL DT; BILDER RM; GOLDMAN RS; LIEBERMAN JA
      EFFECTS OF DOPAMINERGIC MODULATION ON TRAIT-LIKE REDUNDANCY IN SCHIZOPHRENIA

      Biological psychiatry
    77. LENCZ T; TURKEL E; BILDER RM; GOLDMAN RS; LIEBERMAN JA
      WORKING-MEMORY DEFICITS IN SCHIZOPHRENIA PERSIST AFTER MATCHING ON TASK-DIFFICULTY

      Biological psychiatry
    78. GRUBE BS; GOLDMAN RS; ALVIR J; BERGMAN AJ; BILDER RM; LIEBERMAN JA
      SYMPTOM DIMENSIONS IN FIRST-EPISODE SCHIZOPHRENIA - A LONGITUDINAL, CONFIRMATORY FACTOR-ANALYTIC STUDY

      Biological psychiatry
    79. LIEBERMAN JA; MAILMAN R
      DECLINE OF DOPAMINE - EFFECTS OF AGE AND ACUTE NEUROLEPTIC CHALLENGE (VOL 155, PG 319, 1998)

      The American journal of psychiatry
    80. LIEBERMAN JA; MAILMAN R
      DECLINE OF DOPAMINE - EFFECTS OF AGE AND ACUTE NEUROLEPTIC CHALLENGE

      The American journal of psychiatry
    81. PERKINS DO; LIEBERMAN JA
      MEDICAL COMPLICATIONS AND SELECTIVITY OF THERAPEUTIC RESPONSE TO ATYPICAL ANTIPSYCHOTIC-DRUGS

      The American journal of psychiatry
    82. WOERNER MG; ALVIR JMJ; SALTZ BL; LIEBERMAN JA; KANE JM
      PROSPECTIVE-STUDY OF TARDIVE-DYSKINESIA IN THE ELDERLY - RATES AND RISK-FACTORS

      The American journal of psychiatry
    83. BINDER RL; GUZE SB; APPELBAUM PS; LIEBERMAN JA; RABINS PV; OLDHAM JM; BLACKER DL; GELENBERG AJ; RECUPERO PR; OLSON DP; PINCUS HA; ZARIN DA; FERRIS S
      GUIDELINES FOR ASSESSING THE DECISION-MAKING CAPACITIES OF POTENTIAL RESEARCH SUBJECTS WITH COGNITIVE IMPAIRMENT

      The American journal of psychiatry
    84. LIEBERMAN JA
      RECOGNIZING DEPRESSION IN PRIMARY-CARE PATIENTS

      Hospital practice
    85. GILMORE JH; SIKICH L; LIEBERMAN JA
      NEUROIMAGING, NEURODEVELOPMENT, AND SCHIZOPHRENIA

      Child and adolescent psychiatric clinics of North America
    86. WANG GJ; VOLKOW ND; HITZEMANN RJ; WONG C; ANGRIST B; BURR G; PASCANI K; PAPPAS N; LU A; COOPER T; LIEBERMAN JA
      BEHAVIORAL AND CARDIOVASCULAR EFFECTS OF INTRAVENOUS METHYLPHENIDATE IN NORMAL SUBJECTS AND COCAINE ABUSERS

      European addiction research
    87. VINCENT JB; MELTZER HY; LIEBERMAN JA; BRESCHEL T; MCGINNIS M; MACEDO A; AZEVEDO MH; PATO CN; TORREY EF; GOTTESMAN II; PETRONIS A; KENNEDY JL
      LARGE OR EXPANDED CAG CTG TRINUCLEOTIDE REPEATS AS AN ETIOLOGIC FACTOR IN SCHIZOPHRENIA/

      Schizophrenia research
    88. BARR WB; BILDER RM; GOLDMAN RS; LIEBERMAN JA
      NEUROPSYCHOLOGICAL COMPARISON OF EXECUTIVE FUNCTIONS IN FIRST-EPISODESCHIZOPHRENIA AND TEMPORAL-LOBE EPILEPSY

      Schizophrenia research
    89. WILLSON DF; BILDER RM; CHRISTENSEN BK; LIEBERMAN JA
      EXECUTIVE AND ATTENTIONAL FUNCTIONS MEDIATE ACCELERATED FORGETTING INSCHIZOPHRENIA

      Schizophrenia research
    90. CRANDALL DT; SZESZKO PR; BILDER RM; STROUS R; LIEBERMAN JA
      REDUCED ANTERIOR HIPPOCAMPAL VOLUMES ARE ASSOCIATED WITH ALTERNATING RESPONSE PATTERNS IN FIRST EPISODE SCHIZOPHRENIA

      Schizophrenia research
    91. LENCZ T; REDMOND MP; BOOKSTEIN FL; WU HW; BILDER RM; ASHTARI M; LIEBERMAN JA
      MRI LANDMARK SHAPE-ANALYSIS OF NEUROANATOMY IN FIRST-EPISODE SCHIZOPHRENIA

      Schizophrenia research
    92. WU HW; YOUNG L; BOGERTS B; LIEBERMAN JA; BILDER RM
      ABSENCE OF OVERALL CORTICAL AND SUBCORTICAL VOLUME DIFFERENCES AMONG MAJOR MENTAL-DISORDERS

      Schizophrenia research
    93. WOERNER MG; GUNDUZ H; ALVIR JMJ; BILDER R; LIEBERMAN JA
      OBSTETRIC COMPLICATIONS AND BRAIN MRI FINDINGS IN SCHIZOPHRENIA

      Schizophrenia research
    94. TOLLEFSON GD; SANGER TM; LIEBERMAN JA
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF FIRST EPISODE PSYCHOSIS

      Schizophrenia research
    95. ROBINSON DG; LIEBERMAN JA; SHEITMAN B; ALVIR JMJ; KANE JM
      PILOT-STUDY OF ATYPICAL ANTIPSYCHOTIC AGENTS IN FIRST EPISODE SCHIZOPHRENIA

      Schizophrenia research
    96. ALVIR JMJ; WOERNER MG; GUNDUZ H; LIEBERMAN JA
      OBSTETRIC COMPLICATIONS PREDICT TREATMENT RESPONSE IN FIRST EPISODE SCHIZOPHRENIA

      Schizophrenia research
    97. GUNDUZ H; WOERNER MG; ALVIR JMJ; LIEBERMAN JA
      OBSTETRIC COMPLICATIONS IN SCHIZOPHRENIA, AFFECTIVE-DISORDER AND NORMAL CONTROLS

      Schizophrenia research
    98. LIEBERMAN JA; SHEITMAN BB; KINON BJ
      NEUROCHEMICAL SENSITIZATION IN THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA -DEFICITS AND DYSFUNCTION IN NEURONAL REGULATION AND PLASTICITY

      Neuropsychopharmacology
    99. KOREEN AR; LIEBERMAN JA; ALVIR J; CHAKOS M
      THE BEHAVIORAL-EFFECT OF M-CHLOROPHENYLPIPERAZINE (MCPP) AND METHYLPHENIDATE IN FIRST-EPISODE SCHIZOPHRENIA AND NORMAL CONTROLS

      Neuropsychopharmacology
    100. LEE H; SZESZKO PR; CHAKOS M; BILDER RM; LIEBERMAN JA
      CAUDATE-NUCLEUS VOLUME AND COGNITIVE DEFICIT IN FIRST EPISODE PSYCHOSIS

      Archives of clinical neuropsychology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 11:59:28